EDN1 and interstitial lung disease: In IIM, cohort studies have demonstrated higher levels of circulating VCAM-1, ET-1, thrombomodulin, and plasminogen activator inhibitor-1 in IIM patients with ILD compared to IIM without lung disease [26, 27].